Trial Profile
Phase I trial of CCX 140 in volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Sep 2010
Price :
$35
*
At a glance
- Drugs Ilacirnon (Primary)
- Indications Multiple sclerosis; Restenosis; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors ChemoCentryx
- 21 Sep 2010 Results have been presented at the European Association for the Study of Diabetes (EASD), according to a ChemoCentryx media release.
- 21 Sep 2010 Status changed from active, no longer recruiting to completed, according to a ChemoCentryx media release.
- 20 Jun 2008 New trial record.